Sign Up Today and Learn More About Epic Sciences Stock
Invest in or calculate the value of your shares in Epic Sciences or other pre-IPO companies through EquityZen's platform.
Epic Sciences Stock (EPSC)
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
About Epic Sciences Stock
Founded
2008
Headquarters
La Jolla, CA, US
Total Funding
153M
Industries
Science and Engineering, Health Care, Biotechnology
Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.
Epic Sciences Press Mentions
Stay in the know about the latest news on Epic Sciences
ANDROGEN RECEPTOR VARIANT 7 AS A BIOMARKER FOR TREATMENT SELECTION IN PATIENTS …
patents • Apr 14, 2024
Single cell genomic profiling of circulating tumor cells (CTCs) in metastatic …
patents • Apr 14, 2024
Enhanced characterization of breast cancer
patents • Apr 14, 2024
Circulating tumor cell diagnostics for detection of neuroendocrine prostate …
patents • Apr 14, 2024
Intra-patient genomic heterogeneity of single circulating tumor cells (ctcs) …
patents • Apr 14, 2024
Epic Sciences Management
Leadership team at Epic Sciences
Chief Business Officer and General Counsel
Ian Miller
Chief of Medical Innovation; Head of Translational Research Partnerships
Ryan Dittamore
Join now and verify your accreditation status to gain access to:
- Epic Sciences current valuation
- Epic Sciences stock price
- Available deals in Epic Sciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Epic Sciences Stock
How to invest in Epic Sciences stock?
Accredited investors can buy pre-IPO stock in companies like Epic Sciences through EquityZen funds. These investments are made available by existing Epic Sciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Epic Sciences stock?
Shareholders can sell their Epic Sciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
